Wize Pharma's Strategic Transaction Partner Bonus Biogroup Initiates Preclinical Study for Treatment of Respiratory Distress in COVID-19 Patients

Stock Information for Wize Pharma Inc

Loading

Please wait while we load your information from QuoteMedia.